Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT01395758
Status:
COMPLETED
Last Update Posted:
2018-04-03
First Post:
2011-07-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Organization: